Congress is Expected to Bring PBM Transparency Legislation

September 6, 2023

Any federal bill regulating the pharmacy benefit management (PBM) industry that makes it to President Joe Biden’s desk will likely be focused on transparency issues and not on providing broad changes to the industry. Robyn Crosson, JD, Vice President, Government Relations at Navitus Health Solutions was one of several speakers to share her thoughts at the Pharmacy Benefit Management Institute’s annual conference in Orlando.

MORE ABOUT Robyn Crosson

Robyn Crosson is the Vice President of Government Relations at Navitus, where she provides strategic direction on government relations thought-leadership initiatives. She oversees building external relationships with state and federal governments, lobbyists and stakeholders. Her team focuses on legislation and proposed rules/regulations concerning the pharmaceutical, PBM and health care industries.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

Navigating the Key Drivers of Drug Spend and Utilization

Navigating the Key Drivers of Drug Spend and Utilization

Prescription drug spending rose by 11.4% in 2024, reshaping how plan sponsors approach their pharmacy benefit strategy. Costs climbed as existing therapies expanded, new treatments entered the market and coverage decisions shifted pricing dynamics. For…

previous arrow
next arrow